Published in Drug Week, December 24th, 2010
"It has been found that, despite of reactivating potency, this compound has additional effects. These cholinergic effects include a weak inhibition of AChE (IC50 = 43.8 +/- 4.88 mc M), inhibition of binding to the porcine muscarinic M2 receptor (IC50 = 4.36 mc M) and finally, the inhibition of HACU (68.4 +/- 9.9%), a key...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.